Pharmacologic intervention to prevent hemodialysis vascular access thrombosis.
C J
CJ
Diskin
T J
TJ
Stokes
A T
AT
Pennell
D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015118:Eicosapentaenoic Acid / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects; D006023:Glycoproteins / Q000187:drug effects; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011134:Polysaccharides; D006435:Renal Dialysis / Q000009:adverse effects*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D016861:Cyclooxygenase Inhibitors; D006023:Glycoproteins; D010975:Platelet Aggregation Inhibitors; D011134:Polysaccharides; D015118:Eicosapentaenoic Acid